XML 33 R23.htm IDEA: XBRL DOCUMENT
v3.23.3

Note 17 - Segment Reporting | 9 Months Ended
--- | ---
Sep. 30, 2023
Notes to Financial Statements |
Segment Reporting Disclosure [Text Block] | NOTE 17. SEGMENT REPORTING The Company’s chief operating decision maker (“CODM”), who is the Company’s Chief Executive Officer, allocates resources and assesses performance based on financial information of the Company. The CODM reviews financial information presented for each reportable segment for purposes of making operating decisions and assessing financial performance. Prior to the DERMAdoctor Acquisition in November 2021, the Company was managed as a single segment focused on commercializing Avenova Spray in the United States. After the DERMAdoctor Acquisition, the Company began managing and aggregating its operational and financial information in accordance with two reportable segments: (1) Eyecare & Wound Care and (2) Skincare. The Eyecare & Wound Care segment consists of products historically sold by NovaBay prior to the DERMAdoctor Acquisition. The Skincare segment consists of products acquired in the DERMAdoctor Acquisition and skincare products subsequently sold under the DERMAdoctor brand. Select financial information for each segment is as follows:
|  | Three |  |  |  |  |  |  | Three |  |  |  |  |
|  | Months |  |  |  |  |  |  | Months |  |  |  |
|  | Ended |  |  | Percentage |  |  | Ended |  |  | Percentage |
|  | September |  |  | of Total |  |  | September |  |  | of Total |
|  | 30, |  |  | Sales, |  |  | 30, |  |  | Sales, |
|  | 2023 |  |  | Net |  |  | 2022 |  |  | Net |
Eyecare & Wound Care |  | $ | 2,481 |  |  |  | 76 | % |  | $ | 2,507 |  |  |  | 66 | %
Skincare |  |  | 784 |  |  |  | 24 | % |  |  | 1,319 |  |  |  | 34 | %
Total sales, net |  | $ | 3,265 |  |  |  | 100 | % |  | $ | 3,826 |  |  |  | 100 | %
|  | Three |  |  |  |  |  |  | Three |  |  |  |  |
|  | Months |  |  |  |  |  |  | Months |  |  |  |  |
|  | Ended |  |  | Percentage |  |  | Ended |  |  | Percentage |
|  | September |  |  | of Total |  |  | September |  |  | of Total |
|  | 30, |  |  | Operating |  |  | 30, |  |  | Operating |
|  | 2023 |  |  | Loss |  |  | 2022 |  |  | Loss |
Eyecare & Wound Care |  | $ | (698 | ) |  |  | 63 | % |  | $ | (257 | ) |  |  | 56 | %
Skincare |  |  | (418 | ) |  |  | 37 | % |  |  | (200 | ) |  |  | 44 | %
Total operating loss |  | $ | (1,116 | ) |  |  | 100 | % |  | $ | (457 | ) |  |  | 100 | %
|  | Nine Months |  |  |  |  |  |  | Nine Months |  |  |  |  |
|  | Ended |  |  | Percentage |  |  | Ended |  |  | Percentage |
|  | September |  |  | of Total |  |  | September |  |  | of Total |
|  | 30, |  |  | Sales, |  |  | 30, |  |  | Sales, |
|  | 2023 |  |  | Net |  |  | 2022 |  |  | Net |
Eyecare & Wound Care |  | $ | 8,354 |  |  |  | 76 | % |  | $ | 7,646 |  |  |  | 71 | %
Skincare |  |  | 2,645 |  |  |  | 24 | % |  |  | 3,115 |  |  |  | 29 | %
Total sales, net |  | $ | 10,999 |  |  |  | 100 | % |  | $ | 10,761 |  |  |  | 100 | %
|  | Nine Months |  |  |  |  |  |  | Nine Months |  |  |  |  |
|  | Ended |  |  |  |  |  | Ended |  |  |  |
|  | September |  |  | Percentage |  |  | September |  |  | Percentage |
|  | 30, |  |  | of Total |  |  | 30, |  |  | of Total |
|  | 2023 |  |  | Operating Loss |  |  | 2022 |  |  | Operating Loss |
Eyecare & Wound Care |  | $ | (3,094 | ) |  |  | 74 | % |  | $ | (3,605 | ) |  |  | 72 | %
Skincare |  |  | (1,111 | ) |  |  | 26 | % |  |  | (1,386 | ) |  |  | 28 | %
Total operating loss |  | $ | (4,205 | ) |  |  | 100 | % |  | $ | (4,991 | ) |  |  | 100 | %

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//280/tableOfContent Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration